Press-release for stocks

Prices are updated after-hours

crawled date : 2022 - 08 - 04 crawled time : 17:00

save search

Ascendis Pharma A/S Announces Second Quarter 2022 Financial Results and Business Update Conference Call on August 10
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
ASND | $140.19 -0.5% -0.5% 270K

Health Technology

| 57.55% | O: 0.58% H: 3.67% C: 2.3%
pharma conference update results

PDS Biotech Independent Data Monitoring Committee Recommends VERSATILE-002 Trial Continuation without Modifications
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
PDSB | $2.64 -8.97% -9.85% 880K

Health Technology

| -42.89% | O: 0.22% H: 12.58% C: 10.54%
atile-002 biotech continuation trial

Additional Analyses of CRN04894 Preclinical and Phase 1 Results to be Presented at the 10th International Congress of Neuroendocrinology
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
CRNX | $42.98 -0.07% -0.07% 620K

Health Technology

| 115.93% | O: 1.61% H: 6.33% C: 3.86%
crn0489 preclinical results international phase 1

Vaxcyte Provides Positive Regulatory Updates for VAX-24 Adult and Pediatric Programs
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K

Consumer Non-Durables

| -35.09% | O: 0.0% H: 5.96% C: 2.52%
PPRUY | $36.0023 -0.11% 220K

Manufacturing

| -35.91% | O: 0.04% H: 1.21% C: 0.78%
PCVX | $60.82 0.33% 0.33% 1.3M

Health Technology

| 148.39% | O: 1.43% H: 3.54% C: 3.14%
STRO | $3.635 -3.58% -3.71% 520K

Health Technology

| -32.4% | O: 1.68% H: 1.28% C: 0.55%
vax-24 positive

Panbela Expands Aspire Trial to Australia, Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
PBLA | $0.4895 -6.31% 66K

Professional, Scientific, and T...

| -99.97% | O: 1.56% H: 3.05% C: -2.3%
sbp-101 trial gemcitabine pancreatic

Gain Therapeutics to Participate at the 2022 BTIG Biotechnology Conference
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
GANX | $3.155 0.16% 0.16% 71K

Professional, Scientific, and T...

| -22.63% | O: 3.41% H: 0.0% C: -6.59%
conference therapeutics

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -67.35% | O: 5.64% H: 0.0% C: 0.0%
sciences life cancer

Turnkey Replication and Failover
Published: 2022-08-04 (Crawled : 17:00) - snowflake.com
SNOW | News | $145.45 -1.99% -0.08% 5M

Technology Services

| -10.42% | O: -3.45% H: 3.07% C: 2.54%

epay Partners on Ticketing Solution at Grocery POS
Published: 2022-08-04 (Crawled : 17:00) - euronetworldwide.com
EEFT | $102.99 1.16% 1.15% 210K

Technology Services

| 4.79% | O: -0.24% H: 0.14% C: -0.77%
pos

Forecast Report on Global B2B Payments Platform Market Size & Share [2022-2028] Worth USD 1564 Billion | Exhibiting a CAGR of 8.35%: Industry Trends, Demand, Companies, Sales & Analysis | Zion Market Research
Published: 2022-08-04 (Crawled : 17:00) - prnewswire.com
V | $269.78 -0.59% -0.57% 7.8M

Finance

| 29.4% | O: 0.98% H: 2.07% C: 1.4%
BAC | $36.97 3.36% -0.05% 56M

Finance

| 9.9% | O: -0.36% H: 0.45% C: -0.36%
sales research global report platform market

Jury Orders Eli Lilly to Pay $61 Million in Damages for Defrauding Federal Medicaid Program
Published: 2022-08-04 (Crawled : 17:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 131.43% | O: -1.16% H: 0.02% C: -1.42%
program

Arcutis Completes Enrollment in INTEGUMENT-1 Pivotal Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
ARQT | $9.09 -3.81% -3.96% 4.5M

Health Technology

| -59.03% | O: 0.41% H: 10.49% C: 10.36%
dermatitis trial

Introducing Haig Club Clubman Canned Cocktails, A New Range of Premium Ready-To-Enjoy Beverages
Published: 2022-08-04 (Crawled : 17:00) - prnewswire.com
DEO | News | $140.76 -0.02% 8.27% 560K

Consumer Non-Durables

| -26.17% | O: -0.87% H: 0.74% C: 0.53%

Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
RAIN | $1.21 0.0% 3.7M

Manufacturing

| -82.1% | O: 1.48% H: 3.5% C: 3.5%
trial therapeutics

3M Commences Split-Off Exchange Offer for Food Safety Business
Published: 2022-08-04 (Crawled : 17:00) - prnewswire.com
MMM | $92.27 0.86% -0.18% 3.6M

Producer Manufacturing

| -35.7% | O: 0.0% H: 3.37% C: 3.23%
NEOG P | $11.6 -2.77% -2.84% 1.9M

Health Technology

| -47.66% | O: 0.09% H: 0.27% C: -2.88%
food

Century Complete Announces 49 New Homesites in Fairhope, Alabama
Published: 2022-08-04 (Crawled : 17:00) - prnewswire.com
CCS | $79.03 0.32% 0.0% 240K

Consumer Durables

| 62.95% | O: -0.21% H: 4.26% C: 3.1%